Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis

Affiliations

Comment

Mohamed A Elfeki et al. N Engl J Med. 2021.

. 2021 Jun 10;384(23):e90.

doi: 10.1056/NEJMc2105498.

No abstract available

Comment in

Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis. Reply.
China L, Freemantle N, O'Brien A. China L, et al. N Engl J Med. 2021 Jun 10;384(23):e90. doi: 10.1056/NEJMc2105498. N Engl J Med. 2021. PMID: 34107193 No abstract available.

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, Portal AJ, Becares Salles N, Gilroy DW, O'Brien A; ATTIRE Trial Investigators. China L, et al. N Engl J Med. 2021 Mar 4;384(9):808-817. doi: 10.1056/NEJMoa2022166. N Engl J Med. 2021. PMID: 33657293 Clinical Trial.
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, Gonzalez SA, Mumtaz K, Lim N, Simonetto DA, Sharma P, Sanyal AJ, Mayo MJ, Frederick RT, Escalante S, Jamil K; CONFIRM Study Investigators. Wong F, et al. N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290. N Engl J Med. 2021. PMID: 33657294 Clinical Trial.